Product correctly added to cart.

discount label
Tofacitinib Related Compound 26 Hydrochloric Acid Salt
View 3D

TRC logo

Tofacitinib Related Compound 26 Hydrochloric Acid Salt

CAS: 1206824-85-2

Ref. TR-T528035

100mg
3,618.00 €
Estimated delivery in United States, on Thursday 16 Jan 2025

Product Information

Name:
Tofacitinib Related Compound 26 Hydrochloric Acid Salt
Controlled Product
Synonyms:
  • rel-(3R,4R)-4-Methyl-3-(methylamino)-ß-oxo-1-piperidinepropanenitrile Hydrochloride
  • 1-Piperidinepropanenitrile, 4-methyl-3-(methylamino)-β-oxo-, hydrochloride (1:1), (3R,4R)-rel-
Description:

Applications Tofacitinib Related Compound 26 HCl is a related compound of Tofacitinib (T528000), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
References Jiang, J., et. al.: J. med. Chem., 51, 8012 (2008)

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:

Chemical properties

Molecular weight:
231.11384
Formula:
C10H17N3O•(HCl)
Color/Form:
Neat
InChI:
InChI=1S/C10H17N3O.ClH/c1-8-4-6-13(7-9(8)12-2)10(14)3-5-11;/h8-9,12H,3-4,6-7H2,1-2H3;1H/t8-,9+;/m1./s1
SMILES:
CN[C@H]1CN(C(=O)CC#N)CC[C@H]1C.Cl
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TR-T528035 Tofacitinib Related Compound 26 Hydrochloric Acid Salt

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".